The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | Non-opioid and integrative strategies for pain management during VOC in SCD
Claudia Morris, MD, Emory University School of Medicine, Atlanta, GA, discusses the role of non-opioid and integrative strategies, including nutritional supplementation and mind-body therapies, in reducing pain and opioid use during acute vaso-occlusive crises (VOC) in sickle cell disease (SCD). This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
